SCHEMBL2297536

SCHEMBL2297536

NC(=O)C(C(=O)O)C1CCNCC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CPN1 P15169 3/20 0.48
CPB2 Q96IY4 3/20 0.48
GABRA5 P31644 2/20 0.41
GABRB2 P47870 2/20 0.41
GABRP O00591 1/20 0.41
GABRD O14764 1/20 0.41
GABRA1 P14867 1/20 0.41
TSHR P16473 1/20 0.41
GABRB1 P18505 1/20 0.41
GABRG2 P18507 1/20 0.41
GABRB3 P28472 1/20 0.41
GABRA3 P34903 1/20 0.41
GABRA2 P47869 1/20 0.41
GABRA4 P48169 1/20 0.41
GABRE P78334 1/20 0.41
PMP22 Q01453 1/20 0.41
GABRA6 Q16445 1/20 0.41
GABRG1 Q8N1C3 1/20 0.41
GABRG3 Q99928 1/20 0.41
GABRQ Q9UN88 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4593353 0.89 CPN1 (0.44) CPN1CPB2GABRA5GABRB2GABRP
SCHEMBL15910253 0.87 CPN1 (0.55) CPN1CPB2GABRA5GABRB2GABRP
SCHEMBL28196469 0.85 CPN1 (0.53) CPN1CPB2GABRA5GABRB2GABRP
SCHEMBL28855245 0.85 CPN1 (0.53) CPN1CPB2GABRA5GABRB2GABRP
SCHEMBL938927 0.84 EPHX1 (0.41) CPN1CPB2EPHX1
SCHEMBL14311888 0.83 CPN1 (0.40) CPN1CPB2GABRA5GABRB2GABRP
Hydrochloric Acid SCHEMBL27655110 0.82 SLC6A2 (0.40) CPN1CPB2GABRA5GABRB2GABRP
SCHEMBL14048824 0.78 EPHX1 (0.58) PMP22EPHX1DPP4KDM4EMAPT
SCHEMBL4592868 0.77 KDM4E (0.41) CPN1CPB2GABRA5GABRB2GABRP
SCHEMBL4172534 0.76 CPN1 (0.42) CPN1CPB2GABRA5GABRB2GABRP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2536731-A1 SUBSTITUTED SPIROINDOLINONES F. Hoffmann-La Roche AG (CH) 2012-12-26 EP disclosed
WO-2011101297-A1 SUBSTITUTED SPIROINDOLINONES F. HOFFMANN-LA ROCHE AG (CH) 2011-08-25 WO disclosed
EP-1140909-B1 NOVEL INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE SCHERING CORP (US) 2005-07-06 EP disclosed
US-6740661-B2 TRICYCLIC IMINE CONTAINING COMPOUNDS HAVING IMIDAZOLE SUBSTITUENT; ANTITUMOR AGENTS SCHERING CORPORATION 2004-05-25 US disclosed
US-6432959-B1 ANTITUMOR AGENTS SCHERING CORPORATION 2002-08-13 US disclosed
US-6372747-B1 ENZYME INHIBITORS AND ANTICARCINOGENIC AGENTS SCHERING CORPORATION 2002-04-16 US disclosed
EP-1140902-A1 TRICYCLIC FARNESYL PROTEIN TRANSFERASE INHIBITORS SCHERING CORPORATION (US) 2001-10-10 EP disclosed
EP-1140909-A1 NOVEL INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE SCHERING CORPORATION (US) 2001-10-10 EP disclosed
WO-2000039119-A1 NOVEL INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE SCHERING CORPORATION (US) 2000-07-06 WO disclosed
WO-2000037459-A1 TRICYCLIC FARNESYL PROTEIN TRANSFERASE INHIBITORS SCHERING CORPORATION (US) 2000-06-29 WO disclosed